For decades, a safe, affordable, and effective treatment for addiction has existed, yet it remains largely underused: naltrexone. What Is Naltrexone? First developed 60 years ago, naltrexone is a ...

Starting oral or injectable naltrexone at hospital discharge reduced heavy drinking in patients with alcohol use disorder. The hospital is an opportune setting for identifying and treating ...

A new study published in the journal of CNS Drugs showed that low-dose naltrexone (LDN) did not outperform placebo in reducing pain intensity or altering pressure pain thresholds in fibromyalgia ...

The research team utilized data from the Alcohol Disorder Hospital Treatment (ADOPT) study to compare the effectiveness of each type of naltrexone administered to 248 patients with alcohol use ...

The European Medicines Agency (EMA) has concluded a review of the weight loss drug naltrexone/bupropion (Mysimba), which was prompted by concerns about potential long-term cardiovascular risks.

SP-103 has been granted Fast Track status from the FDA in low back pain; and (iii) SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (“SP-104”), a novel low-dose ...

A literature search identified more than a dozen published reports on the use of pure opioid antagonists (naloxone, naltrexone, methylnaltrexone) for the management of OIP in pediatric and adult ...